phosphorylase/infarction

Lyen an sove nan clipboard la

Chwazi kalite sòt

Paj 1 soti nan 89 rezilta yo

[Glycogen phosphorylase activity in acute myocardial infarction].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The activity of glycogen phosphorylase (GP) and creatine phosphokinase isoenzyme MB (CPK MB) was measured in patients with myocardial infarction over 72 hours after the anginal attack. In most clinical observations, CPK MB and GP patterns were similar, however, the GP activity reached its peak 4-6

[Glycogen phosphorylase activity in infarct-affected and nonaffected parts of the human myocardium after death].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Distinct differences in activity of glycogen phosphorylase were not observed in various parts of an intact human myocardium. This enzymatic activity vas considerably decreased in the left ventricle of the myocardium impaired by infarction; with prolongation of the infarction period the enzymatic

The assay of glycogen phosphorylase in human blood serum and its application to the diagnosis of myocardial infarction.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Methods are described (a) for the estimation of glycogen phosphorylase activity (EC 2.4.1.1) in human blood serum based on the chemical determination of liberated orthophosphate or on the enzymic determination of glucose 1-phosphate in a coupled assay system and (b) for the electrophoretic

Glycogen phosphorylase BB in myocardial infarction.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Early experimental and clinical reports on glycogen phosphorylase BB (GPBB) kinetics following myocardial ischemic injury suggested that it could be a useful diagnostic marker for early detection of acute myocardial infarction (AMI). After more than two decades of investigation, there is now

Glycogen Phosphorylase BB: A more Sensitive and Specific Marker than Other Cardiac Markers for Early Diagnosis of Acute Myocardial Infarction.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Cardiac markers are used to evaluate functions of heart. However, there are no satisfactory cardiac biomarkers for the diagnosis of acute myocardial infarction (AMI) within 4 h of onset of chest pain. Among novel cardiac markers, glycogen phosphorylase BB (GPBB) is of particular interest as it is

Glycogen phosphorylase isoenzyme BB in diagnosis of myocardial ischaemic injury and infarction.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

This review deals with glycogen phosphorylase (GP) and its isoenzyme BB in the diagnosis of ischaemic myocardial injury. Early identification and confirmation of acute myocardial infarction is essential for correct patient care and disposition decision in the emergency department. In this respect,

[Association between methylthioadenosine phosphorylase gene single nucleotide polymorphisms and myocardial infarction in Chinese Han ethnicity].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE To investigate the association between methylthioadenosine phosphorylase (MTAP) gene single nucleotide polymorphisms (SNP) and myocardial infarction (MI) in the Chinese Han ethnicity. METHODS 432 patients suffered from myocardial infarction and 430 controls were involved for case and

Diagnostic accuracy of heart fatty acid binding protein (H-FABP) and glycogen phosphorylase isoenzyme BB (GPBB) in diagnosis of acute myocardial infarction in patients with acute coronary syndrome.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND This study aimed to assess whether heart fatty acid-binding protein (H-FABP) and glycogen phosphorylase isoenzyme BB (GPBB) could be used for the accurate diagnosis of acute myocardial infarction (AMI) in acute coronary syndrome (ACS) patients. METHODS The study included 108 ACS patients

Glycogen phosphorylase isoenzyme BB in the diagnosis of acute myocardial infarction: a meta-analysis.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND Early diagnosis is crucial for management of patients with suspected acute myocardial infarction (AMI). Among innovative and promising biomarkers, the recent interest raised on glycogen phosphorylase isoenzyme BB (GPBB) has prompted us to perform a meta-analysis of published

[Determination of glycogen phosphorylase B--a contribution to the enzymatic diagnosis of acute myocardial infarct].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

On the basis of a small number of patients with the tentative diagnosis acute myocardial infarction the diagnostic valency of the glycogen phosphorylase was tested. A separation between severe stenocardia and myocardial infarction is possible. After simplification of the methodology the glycogen

Herbal & Natural Medicine

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye

phosphorylase/infarction

[Glycogen phosphorylase activity in acute myocardial infarction].

[Glycogen phosphorylase activity in infarct-affected and nonaffected parts of the human myocardium after death].

The assay of glycogen phosphorylase in human blood serum and its application to the diagnosis of myocardial infarction.

Glycogen phosphorylase BB in myocardial infarction.

Glycogen Phosphorylase BB: A more Sensitive and Specific Marker than Other Cardiac Markers for Early Diagnosis of Acute Myocardial Infarction.

Glycogen phosphorylase isoenzyme BB in diagnosis of myocardial ischaemic injury and infarction.

[Association between methylthioadenosine phosphorylase gene single nucleotide polymorphisms and myocardial infarction in Chinese Han ethnicity].

Diagnostic accuracy of heart fatty acid binding protein (H-FABP) and glycogen phosphorylase isoenzyme BB (GPBB) in diagnosis of acute myocardial infarction in patients with acute coronary syndrome.

Glycogen phosphorylase isoenzyme BB in the diagnosis of acute myocardial infarction: a meta-analysis.

[Determination of glycogen phosphorylase B--a contribution to the enzymatic diagnosis of acute myocardial infarct].

[Immunoinhibition test for human glycogen phosphorylase BB in the diagnosis of acute myocardial infarct].

[Dynamics of blood glycogen phosphorylase during acute myocardial infarct].

[On the histochemical demonstration of phosphorylases in myocardial infarct].

Isoenzyme BB of glycogen phosphorylase b and myocardial infarction.

Phosphorylase activity of the subendocardial myofibrils in infarction and in strangulation.

Baz done ki pi konplè remèd fèy medsin te apiye nan syans